[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Gene Editing Technologies Market Size, Status and Forecast 2020-2026

July 2020 | 91 pages | ID: C15CBD301295EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Editing Technologies market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Gene Editing Technologies industry.

Based on our recent survey, we have several different scenarios about the Gene Editing Technologies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Editing Technologies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Editing Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Editing Technologies market in terms of revenue.

Players, stakeholders, and other participants in the global Gene Editing Technologies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Editing Technologies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Gene Editing Technologies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Editing Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Editing Technologies market.

The following players are covered in this report:
  • Thermo Fisher Scientific
  • Merck
  • Sangamo Therapeutics
  • Lonza
  • Transposagen Biopharmaceuticals
  • Editas Medicine
  • CRISPR Therapeutics
  • Agilent Technologies
Gene Editing Technologies Breakdown Data by Type
  • Double Strand Break Repair
  • Engineered Nucleases
  • Clustered Regularly Interspaced Short Palindromic Repeats
Gene Editing Technologies Breakdown Data by Application
  • Gene Therapy
  • Eradicating Diseases
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Editing Technologies Revenue
1.4 Market Analysis by Type
  1.4.1 Global Gene Editing Technologies Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Double Strand Break Repair
  1.4.3 Engineered Nucleases
  1.4.4 Clustered Regularly Interspaced Short Palindromic Repeats
1.5 Market by Application
  1.5.1 Global Gene Editing Technologies Market Share by Application: 2020 VS 2026
  1.5.2 Gene Therapy
  1.5.3 Eradicating Diseases
1.6 Coronavirus Disease 2019 (Covid-19): Gene Editing Technologies Industry Impact
  1.6.1 How the Covid-19 is Affecting the Gene Editing Technologies Industry
    1.6.1.1 Gene Editing Technologies Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Gene Editing Technologies Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Gene Editing Technologies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Gene Editing Technologies Market Perspective (2015-2026)
2.2 Gene Editing Technologies Growth Trends by Regions
  2.2.1 Gene Editing Technologies Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Gene Editing Technologies Historic Market Share by Regions (2015-2020)
  2.2.3 Gene Editing Technologies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Gene Editing Technologies Market Growth Strategy
  2.3.6 Primary Interviews with Key Gene Editing Technologies Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Gene Editing Technologies Players by Market Size
  3.1.1 Global Top Gene Editing Technologies Players by Revenue (2015-2020)
  3.1.2 Global Gene Editing Technologies Revenue Market Share by Players (2015-2020)
  3.1.3 Global Gene Editing Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Editing Technologies Market Concentration Ratio
  3.2.1 Global Gene Editing Technologies Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Gene Editing Technologies Revenue in 2019
3.3 Gene Editing Technologies Key Players Head office and Area Served
3.4 Key Players Gene Editing Technologies Product Solution and Service
3.5 Date of Enter into Gene Editing Technologies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Gene Editing Technologies Historic Market Size by Type (2015-2020)
4.2 Global Gene Editing Technologies Forecasted Market Size by Type (2021-2026)

5 GENE EDITING TECHNOLOGIES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Gene Editing Technologies Market Size by Application (2015-2020)
5.2 Global Gene Editing Technologies Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Gene Editing Technologies Market Size (2015-2020)
6.2 Gene Editing Technologies Key Players in North America (2019-2020)
6.3 North America Gene Editing Technologies Market Size by Type (2015-2020)
6.4 North America Gene Editing Technologies Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Gene Editing Technologies Market Size (2015-2020)
7.2 Gene Editing Technologies Key Players in Europe (2019-2020)
7.3 Europe Gene Editing Technologies Market Size by Type (2015-2020)
7.4 Europe Gene Editing Technologies Market Size by Application (2015-2020)

8 CHINA

8.1 China Gene Editing Technologies Market Size (2015-2020)
8.2 Gene Editing Technologies Key Players in China (2019-2020)
8.3 China Gene Editing Technologies Market Size by Type (2015-2020)
8.4 China Gene Editing Technologies Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Gene Editing Technologies Market Size (2015-2020)
9.2 Gene Editing Technologies Key Players in Japan (2019-2020)
9.3 Japan Gene Editing Technologies Market Size by Type (2015-2020)
9.4 Japan Gene Editing Technologies Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Gene Editing Technologies Market Size (2015-2020)
10.2 Gene Editing Technologies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Editing Technologies Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Editing Technologies Market Size by Application (2015-2020)

11 INDIA

11.1 India Gene Editing Technologies Market Size (2015-2020)
11.2 Gene Editing Technologies Key Players in India (2019-2020)
11.3 India Gene Editing Technologies Market Size by Type (2015-2020)
11.4 India Gene Editing Technologies Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Gene Editing Technologies Market Size (2015-2020)
12.2 Gene Editing Technologies Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Editing Technologies Market Size by Type (2015-2020)
12.4 Central & South America Gene Editing Technologies Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Thermo Fisher Scientific
  13.1.1 Thermo Fisher Scientific Company Details
  13.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  13.1.3 Thermo Fisher Scientific Gene Editing Technologies Introduction
  13.1.4 Thermo Fisher Scientific Revenue in Gene Editing Technologies Business (2015-2020))
  13.1.5 Thermo Fisher Scientific Recent Development
13.2 Merck
  13.2.1 Merck Company Details
  13.2.2 Merck Business Overview and Its Total Revenue
  13.2.3 Merck Gene Editing Technologies Introduction
  13.2.4 Merck Revenue in Gene Editing Technologies Business (2015-2020)
  13.2.5 Merck Recent Development
13.3 Sangamo Therapeutics
  13.3.1 Sangamo Therapeutics Company Details
  13.3.2 Sangamo Therapeutics Business Overview and Its Total Revenue
  13.3.3 Sangamo Therapeutics Gene Editing Technologies Introduction
  13.3.4 Sangamo Therapeutics Revenue in Gene Editing Technologies Business (2015-2020)
  13.3.5 Sangamo Therapeutics Recent Development
13.4 Lonza
  13.4.1 Lonza Company Details
  13.4.2 Lonza Business Overview and Its Total Revenue
  13.4.3 Lonza Gene Editing Technologies Introduction
  13.4.4 Lonza Revenue in Gene Editing Technologies Business (2015-2020)
  13.4.5 Lonza Recent Development
13.5 Transposagen Biopharmaceuticals
  13.5.1 Transposagen Biopharmaceuticals Company Details
  13.5.2 Transposagen Biopharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Transposagen Biopharmaceuticals Gene Editing Technologies Introduction
  13.5.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Technologies Business (2015-2020)
  13.5.5 Transposagen Biopharmaceuticals Recent Development
13.6 Editas Medicine
  13.6.1 Editas Medicine Company Details
  13.6.2 Editas Medicine Business Overview and Its Total Revenue
  13.6.3 Editas Medicine Gene Editing Technologies Introduction
  13.6.4 Editas Medicine Revenue in Gene Editing Technologies Business (2015-2020)
  13.6.5 Editas Medicine Recent Development
13.7 CRISPR Therapeutics
  13.7.1 CRISPR Therapeutics Company Details
  13.7.2 CRISPR Therapeutics Business Overview and Its Total Revenue
  13.7.3 CRISPR Therapeutics Gene Editing Technologies Introduction
  13.7.4 CRISPR Therapeutics Revenue in Gene Editing Technologies Business (2015-2020)
  13.7.5 CRISPR Therapeutics Recent Development
13.8 Agilent Technologies
  13.8.1 Agilent Technologies Company Details
  13.8.2 Agilent Technologies Business Overview and Its Total Revenue
  13.8.3 Agilent Technologies Gene Editing Technologies Introduction
  13.8.4 Agilent Technologies Revenue in Gene Editing Technologies Business (2015-2020)
  13.8.5 Agilent Technologies Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Gene Editing Technologies Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Editing Technologies Revenue
Table 3. Ranking of Global Top Gene Editing Technologies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Editing Technologies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Double Strand Break Repair
Table 6. Key Players of Engineered Nucleases
Table 7. Key Players of Clustered Regularly Interspaced Short Palindromic Repeats
Table 8. COVID-19 Impact Global Market: (Four Gene Editing Technologies Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Gene Editing Technologies Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Gene Editing Technologies Players to Combat Covid-19 Impact
Table 13. Global Gene Editing Technologies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Gene Editing Technologies Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Gene Editing Technologies Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Gene Editing Technologies Market Share by Regions (2015-2020)
Table 17. Global Gene Editing Technologies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Gene Editing Technologies Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Gene Editing Technologies Market Growth Strategy
Table 23. Main Points Interviewed from Key Gene Editing Technologies Players
Table 24. Global Gene Editing Technologies Revenue by Players (2015-2020) (Million US$)
Table 25. Global Gene Editing Technologies Market Share by Players (2015-2020)
Table 26. Global Top Gene Editing Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Editing Technologies as of 2019)
Table 27. Global Gene Editing Technologies by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Gene Editing Technologies Product Solution and Service
Table 30. Date of Enter into Gene Editing Technologies Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Gene Editing Technologies Market Size by Type (2015-2020) (Million US$)
Table 33. Global Gene Editing Technologies Market Size Share by Type (2015-2020)
Table 34. Global Gene Editing Technologies Revenue Market Share by Type (2021-2026)
Table 35. Global Gene Editing Technologies Market Size Share by Application (2015-2020)
Table 36. Global Gene Editing Technologies Market Size by Application (2015-2020) (Million US$)
Table 37. Global Gene Editing Technologies Market Size Share by Application (2021-2026)
Table 38. North America Key Players Gene Editing Technologies Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Gene Editing Technologies Market Share (2019-2020)
Table 40. North America Gene Editing Technologies Market Size by Type (2015-2020) (Million US$)
Table 41. North America Gene Editing Technologies Market Share by Type (2015-2020)
Table 42. North America Gene Editing Technologies Market Size by Application (2015-2020) (Million US$)
Table 43. North America Gene Editing Technologies Market Share by Application (2015-2020)
Table 44. Europe Key Players Gene Editing Technologies Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Gene Editing Technologies Market Share (2019-2020)
Table 46. Europe Gene Editing Technologies Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Gene Editing Technologies Market Share by Type (2015-2020)
Table 48. Europe Gene Editing Technologies Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Gene Editing Technologies Market Share by Application (2015-2020)
Table 50. China Key Players Gene Editing Technologies Revenue (2019-2020) (Million US$)
Table 51. China Key Players Gene Editing Technologies Market Share (2019-2020)
Table 52. China Gene Editing Technologies Market Size by Type (2015-2020) (Million US$)
Table 53. China Gene Editing Technologies Market Share by Type (2015-2020)
Table 54. China Gene Editing Technologies Market Size by Application (2015-2020) (Million US$)
Table 55. China Gene Editing Technologies Market Share by Application (2015-2020)
Table 56. Japan Key Players Gene Editing Technologies Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Gene Editing Technologies Market Share (2019-2020)
Table 58. Japan Gene Editing Technologies Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Gene Editing Technologies Market Share by Type (2015-2020)
Table 60. Japan Gene Editing Technologies Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Gene Editing Technologies Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Gene Editing Technologies Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Gene Editing Technologies Market Share (2019-2020)
Table 64. Southeast Asia Gene Editing Technologies Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Gene Editing Technologies Market Share by Type (2015-2020)
Table 66. Southeast Asia Gene Editing Technologies Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Gene Editing Technologies Market Share by Application (2015-2020)
Table 68. India Key Players Gene Editing Technologies Revenue (2019-2020) (Million US$)
Table 69. India Key Players Gene Editing Technologies Market Share (2019-2020)
Table 70. India Gene Editing Technologies Market Size by Type (2015-2020) (Million US$)
Table 71. India Gene Editing Technologies Market Share by Type (2015-2020)
Table 72. India Gene Editing Technologies Market Size by Application (2015-2020) (Million US$)
Table 73. India Gene Editing Technologies Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Gene Editing Technologies Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Gene Editing Technologies Market Share (2019-2020)
Table 76. Central & South America Gene Editing Technologies Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Gene Editing Technologies Market Share by Type (2015-2020)
Table 78. Central & South America Gene Editing Technologies Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Gene Editing Technologies Market Share by Application (2015-2020)
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Product
Table 83. Thermo Fisher Scientific Revenue in Gene Editing Technologies Business (2015-2020) (Million US$)
Table 84. Thermo Fisher Scientific Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Gene Editing Technologies Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Sangamo Therapeutics Company Details
Table 91. Sangamo Therapeutics Business Overview
Table 92. Sangamo Therapeutics Product
Table 93. Sangamo Therapeutics Revenue in Gene Editing Technologies Business (2015-2020) (Million US$)
Table 94. Sangamo Therapeutics Recent Development
Table 95. Lonza Company Details
Table 96. Lonza Business Overview
Table 97. Lonza Product
Table 98. Lonza Revenue in Gene Editing Technologies Business (2015-2020) (Million US$)
Table 99. Lonza Recent Development
Table 100. Transposagen Biopharmaceuticals Company Details
Table 101. Transposagen Biopharmaceuticals Business Overview
Table 102. Transposagen Biopharmaceuticals Product
Table 103. Transposagen Biopharmaceuticals Revenue in Gene Editing Technologies Business (2015-2020) (Million US$)
Table 104. Transposagen Biopharmaceuticals Recent Development
Table 105. Editas Medicine Company Details
Table 106. Editas Medicine Business Overview
Table 107. Editas Medicine Product
Table 108. Editas Medicine Revenue in Gene Editing Technologies Business (2015-2020) (Million US$)
Table 109. Editas Medicine Recent Development
Table 110. CRISPR Therapeutics Company Details
Table 111. CRISPR Therapeutics Business Overview
Table 112. CRISPR Therapeutics Product
Table 113. CRISPR Therapeutics Revenue in Gene Editing Technologies Business (2015-2020) (Million US$)
Table 114. CRISPR Therapeutics Recent Development
Table 115. Agilent Technologies Business Overview
Table 116. Agilent Technologies Product
Table 117. Agilent Technologies Company Details
Table 118. Agilent Technologies Revenue in Gene Editing Technologies Business (2015-2020) (Million US$)
Table 119. Agilent Technologies Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Gene Editing Technologies Market Share by Type: 2020 VS 2026
Figure 2. Double Strand Break Repair Features
Figure 3. Engineered Nucleases Features
Figure 4. Clustered Regularly Interspaced Short Palindromic Repeats Features
Figure 5. Global Gene Editing Technologies Market Share by Application: 2020 VS 2026
Figure 6. Gene Therapy Case Studies
Figure 7. Eradicating Diseases Case Studies
Figure 8. Gene Editing Technologies Report Years Considered
Figure 9. Global Gene Editing Technologies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Gene Editing Technologies Market Share by Regions: 2020 VS 2026
Figure 11. Global Gene Editing Technologies Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Gene Editing Technologies Market Share by Players in 2019
Figure 14. Global Top Gene Editing Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Editing Technologies as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Gene Editing Technologies Revenue in 2019
Figure 16. North America Gene Editing Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Gene Editing Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Gene Editing Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Gene Editing Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Gene Editing Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Gene Editing Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Gene Editing Technologies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Thermo Fisher Scientific Revenue Growth Rate in Gene Editing Technologies Business (2015-2020)
Figure 25. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Merck Revenue Growth Rate in Gene Editing Technologies Business (2015-2020)
Figure 27. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sangamo Therapeutics Revenue Growth Rate in Gene Editing Technologies Business (2015-2020)
Figure 29. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Lonza Revenue Growth Rate in Gene Editing Technologies Business (2015-2020)
Figure 31. Transposagen Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Transposagen Biopharmaceuticals Revenue Growth Rate in Gene Editing Technologies Business (2015-2020)
Figure 33. Editas Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Editas Medicine Revenue Growth Rate in Gene Editing Technologies Business (2015-2020)
Figure 35. CRISPR Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Technologies Business (2015-2020)
Figure 37. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Agilent Technologies Revenue Growth Rate in Gene Editing Technologies Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed


More Publications